Cargando…

Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis

Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm whose severity and treatment complexity are attributed to the presence of bone marrow (BM) fibrosis and alterations of stroma impairing the production of normal blood cells. Despite the recently discovered mutations including the JA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinaud, Christophe, Desterke, Christophe, Konopacki, Johanna, Vannucchi, Alessandro M., Pieri, Lisa, Guglielmelli, Paola, Dupriez, Brigitte, Ianotto, Jean-Christophe, Boutin, Laetitia, Lataillade, Jean-Jacques, Le Bousse-Kerdilès, Marie-Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Data in Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583614/ https://www.ncbi.nlm.nih.gov/pubmed/26484208 http://dx.doi.org/10.1016/j.gdata.2015.04.017

Ejemplares similares

Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis
por: Desterke, Christophe, et al.
Publicado: (2015)

Assessment of sites of marrow and extramedullary hematopoiesis by hybrid imaging in primary myelofibrosis patients
por: Ojeda‐Uribe, Mario, et al.
Publicado: (2016)

Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation
por: Boutin, Laetitia, et al.
Publicado: (2020)

Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
por: Peltzer, Juliette, et al.
Publicado: (2018)

Primary myelofibrosis and the "bad seeds in bad soil" concept
por: Le Bousse-Kerdilès, Marie-Caroline
Publicado: (2012)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
por: Amé, Shanti, et al.
Publicado: (2023)

Effect of Allogeneic Oral Mucosa Mesenchymal Stromal Cells on Equine Wound Repair
por: Di Francesco, Paola, et al.
Publicado: (2021)

Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis
por: Sureau, Léa, et al.
Publicado: (2021)

Myelofibrosis Treatment Algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Pegylated interferon 2a and ruxolitinib induce a high rate of oral complications among patients with myeloproliferative neoplasms
por: Orliaguet, Marie, et al.
Publicado: (2020)

Separate and combined effects of hypobaric hypoxia and hindlimb suspension on skeletal homeostasis and hematopoiesis in mice
por: Durand, Marjorie, et al.
Publicado: (2019)

Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
por: Zingariello, Maria, et al.
Publicado: (2020)

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
por: Ianotto, Jean-Christophe, et al.
Publicado: (2018)

Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial
por: Pardanani, A, et al.
Publicado: (2015)

Leptin receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis
por: Decker, Matthew, et al.
Publicado: (2017)

Peripheral denervation participates in heterotopic ossification in a spinal cord injury model
por: Debaud, Charlotte, et al.
Publicado: (2017)

Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells
por: Aussel, Clotilde, et al.
Publicado: (2022)

Inferring Gene Networks in Bone Marrow Hematopoietic Stem Cell-Supporting Stromal Niche Populations
por: Desterke, Christophe, et al.
Publicado: (2020)

Neurogenic Heterotopic Ossifications Recapitulate Hematopoietic Stem Cell Niche Development Within an Adult Osteogenic Muscle Environment
por: Girard, Dorothée, et al.
Publicado: (2021)

Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea
por: Pacilli, Annalisa, et al.
Publicado: (2018)

Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis
por: Coltro, Giacomo, et al.
Publicado: (2022)

Therapeutic Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Prevention of Organ Injuries Induced by Traumatic Hemorrhagic Shock
por: Valade, Guillaume, et al.
Publicado: (2021)

Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
por: Leimkühler, Nils B., et al.
Publicado: (2021)

Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells
por: Guglielmelli, Paola, et al.
Publicado: (2015)

Biological drivers of clinical phenotype in myelofibrosis
por: Mascarenhas, John, et al.
Publicado: (2022)

Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
por: Guglielmelli, Paola, et al.
Publicado: (2020)

A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis
por: Carobbio, Alessandra, et al.
Publicado: (2020)

Incidence of blast phase in myelofibrosis according to anemia severity
por: Mora, Barbara, et al.
Publicado: (2023)

Prefibrotic myelofibrosis: treatment algorithm 2018
por: Finazzi, Guido, et al.
Publicado: (2018)

Comparative study of minutiae selection methods for digital fingerprints
por: Vibert, Benoit, et al.
Publicado: (2023)

Impact of HCV Infection on Hepatocyte Polarity and Plasticity
por: Agnetti, Jean, et al.
Publicado: (2022)

Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
por: Guglielmelli, P, et al.
Publicado: (2015)

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Primary myelofibrosis evolving to an aplastic appearing marrow
por: Schaefer, Jordan K., et al.
Publicado: (2018)

Chronic Myeloproliferative Neoplasms: a Collaborative Approach
por: Pieri, Lisa, et al.
Publicado: (2010)

Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis
por: Guglielmelli, Paola, et al.
Publicado: (2023)

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review
por: Ianotto, Jean-Christophe, et al.
Publicado: (2019)

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells
por: Najar, Mehdi, et al.
Publicado: (2016)

S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
por: Gleitz, Hélène, et al.
Publicado: (2023)

Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model
por: Bianchi, Elisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k5rumrius7ubemtk613pv2atlq